Published in Am J Med Genet on July 08, 2001
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav Genet (2007) 1.84
5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am J Med Genet B Neuropsychiatr Genet (2009) 1.49
Genetic contributions of the serotonin transporter to social learning of fear and economic decision making. Soc Cogn Affect Neurosci (2009) 1.26
Polymorphisms in the serotonin reuptake transporter gene modify the consequences of social status on metabolic health in female rhesus monkeys. Physiol Behav (2007) 1.23
Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population. Eur Arch Psychiatry Clin Neurosci (2008) 1.04
Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biol Mood Anxiety Disord (2013) 1.01
Social subordination and polymorphisms in the gene encoding the serotonin transporter enhance estradiol inhibition of luteinizing hormone secretion in female rhesus monkeys. Biol Reprod (2009) 0.98
T-cell phenotypic and functional changes associated with social subordination and gene polymorphisms in the serotonin reuptake transporter in female rhesus monkeys. Brain Behav Immun (2008) 0.98
Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder. J Psychiatry Neurosci (2009) 0.94
Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice. Eur Neuropsychopharmacol (2010) 0.93
Personality traits of agreeableness and extraversion are associated with ADH4 variation. Biol Psychiatry (2006) 0.92
A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Psychopharmacology (Berl) (2007) 0.89
The association between serotonin transporter gene promoter polymorphism (5-HTTLPR), self-reported symptoms, and dental mercury exposure. J Toxicol Environ Health A (2008) 0.88
Stress and the reproductive axis. J Neuroendocrinol (2014) 0.84
Gene-environment interactions, not neonatal growth hormone deficiency, time puberty in female rhesus monkeys. Biol Reprod (2007) 0.82
Genetic, epigenetic and environmental impact on sex differences in social behavior. Physiol Behav (2009) 0.81
No association between 5-HTTLPR and harm avoidance in Korean college students. J Korean Med Sci (2007) 0.79
Placebo analgesia: cognitive influences on therapeutic outcome. Arthritis Res Ther (2012) 0.79
Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype. J Child Adolesc Psychopharmacol (2015) 0.75
Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders. J Neurosci Res (2017) 0.75
How possible is the development of an operational psychometric method to assess the presence of the 5-HTTLPR s allele? Equivocal preliminary findings. Ann Gen Psychiatry (2010) 0.75
Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43
Cytotoxic effects of lymphoid cells in vitro. Adv Immunol (1969) 8.18
Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors. Int Arch Allergy Appl Immunol (1970) 5.92
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest (1983) 4.70
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
Cytotoxic potential of stimulated human lymphocytes. J Exp Med (1967) 3.89
Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology (1967) 3.87
Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab (1998) 3.75
Facial nerve palsy in the newborn: incidence and outcome. Plast Reconstr Surg (1990) 2.84
Phytohaemagglutinin-induced cytotoxic action of unsensitized immunologically competent cells on allogeneic and xenogeneic tissue culture cells. Nature (1965) 2.69
Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant (2011) 2.54
Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A (1993) 2.51
Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Diabet Med (1999) 2.48
Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet (1986) 2.38
Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab (1997) 2.31
Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther (1998) 2.29
The health consequences of moderate obesity. Int J Obes (1981) 2.21
Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum. Clin Exp Immunol (1973) 2.21
Obesity and cortisol. Nutrition (2000) 2.17
Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes. Science (1968) 2.17
The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med (2000) 2.14
Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci U S A (1994) 2.02
Androgen treatment of abdominally obese men. Obes Res (1993) 1.99
A European ACL register. Knee Surg Sports Traumatol Arthrosc (2006) 1.98
Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta Psychiatr Scand (2011) 1.97
Sjöström L,+SJOSTROM L: Number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism (1971) 1.80
Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells. J Lipid Res (1971) 1.79
Testosterone concentrations in women and men with NIDDM. Diabetes Care (1994) 1.78
Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J Immunol (1987) 1.78
Lysis of antibody-treated human erythrocytes by human leukocytes and macrophages in tissue culture. Int Arch Allergy Appl Immunol (1972) 1.77
Does amateur boxing lead to chronic brain damage? A review of some recent investigations. Am J Sports Med (1993) 1.77
Healing of partial thickness porcine skin wounds in a liquid environment. J Surg Res (1992) 1.72
The in vitro cytotoxicity of human lymphocytes: the effect of metabolic inhibitors. Exp Cell Res (1967) 1.72
Do we need a gender-specific total knee replacement? A randomised controlled trial comparing a high-flex and a gender-specific posterior design. J Bone Joint Surg Br (2012) 1.71
Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med (1989) 1.70
Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord (2000) 1.67
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol (1992) 1.66
Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol (2000) 1.66
Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism (1990) 1.63
Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism (1978) 1.62
Immune deficiency in family members of patients with Hodgkin's disease. Cancer (1990) 1.61
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord (1992) 1.61
Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab (1995) 1.58
Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia. Clin Exp Immunol (1967) 1.57
The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism (1992) 1.56
Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care (1994) 1.55
Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia (1988) 1.53
Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism (1992) 1.52
A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res (2000) 1.52
Hamstring injuries in sprinters. The role of concentric and eccentric hamstring muscle strength and flexibility. Am J Sports Med (1994) 1.51
Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med (1995) 1.51
Haemodynamic effects of physical training in coronary patients. Lancet (1966) 1.51
The biomechanics of anterior cruciate ligament rehabilitation and reconstruction. Am J Sports Med (1984) 1.50
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ (1990) 1.50
Variation of flavonoid patterns in Hordeum spontaneum and H. agriocrithon. Hereditas (1975) 1.49
Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol (1974) 1.49
Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance. Eur J Haematol (1989) 1.48
Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem (1998) 1.48
Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb (1992) 1.46
The effect of physical training on insulin production in obesity. Metabolism (1970) 1.45
Body composition and adipose cellularity in human obesity. Acta Med Scand (1974) 1.45
The glucose uptake of human adipose tissue in obesity. Eur J Clin Invest (1971) 1.44
Urinary albumin excretion and heart rate variability in obese women. Int J Obes Relat Metab Disord (1998) 1.44
Gene therapy in wound repair and regeneration. Wound Repair Regen (2001) 1.44
Aneurysm sac hygroma: a cause of endotension. J Endovasc Ther (2001) 1.44
Plasma free fatty acid turnover rate in obesity. Acta Med Scand (1969) 1.43
Uptake of triglyceride fatty acids in adipose tissue in vivo in man. Eur J Clin Invest (1990) 1.43
Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J Lipid Res (1978) 1.43
Lymphocyte subpopulations in sarcoidosis. Clin Exp Immunol (1974) 1.43
Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit? J Intern Med (1994) 1.41
In vitro cytotoxic effects of lymphoid cells from rats with experimental autoimmune nephrosis. Clin Exp Immunol (1966) 1.41
Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest (1985) 1.40
Cylinder or mobile cast brace after knee ligament surgery. A clinical analysis and morphologic and enzymatic studies of changes in the quadriceps muscle. Am J Sports Med (1979) 1.35
Cancer patients' views and experiences of participation in care and decision making. Nurs Ethics (2001) 1.34
Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes (1991) 1.34
Hypothalamic origin of the metabolic syndrome X. Ann N Y Acad Sci (1999) 1.33
The metabolic syndrome--a neuroendocrine disorder? Br J Nutr (2000) 1.33
Comparison of thermoregulatory function in men and women. J Appl Physiol (1969) 1.33
Cytotoxicity of lymphocytes and its suppression. Antibiot Chemother (1969) 1.32
Treatment of angina pectoris with beta-receptor blockade, mode of action. Acta Med Scand (1968) 1.31
Stress fractures of the femoral neck in athletes. The consequence of a delay in diagnosis. Am J Sports Med (1991) 1.30
Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab (2001) 1.30
Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism (1989) 1.29
Body fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism (1977) 1.28
Regional adipose tissue cellularity in relation to metabolism in young and middle-aged women. Metabolism (1975) 1.28
Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab (2001) 1.28
Microvascular dimensions and blood flow in skeletal muscle. Acta Physiol Scand (1972) 1.27
In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers. Clin Exp Immunol (1973) 1.26